EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

How representative are the surveillance, epidemiology, and end results (SEER) Program cancer data of the United States?



How representative are the surveillance, epidemiology, and end results (SEER) Program cancer data of the United States?



Cancer Causes and Control 15(10): 1027-1034



Objective: Data from the 11 Surveillance, Epidemiology, and End Results tumor registries cover 14% of the US population and are often used to provide national estimates of cancer incidence and survival. Cancer mortality data for the US and for SEER are compared to assess the representation of SEER to the US. Methods: Comparisons between US and SEER cancer mortality were made for 16 of the leading causes of cancer death. Cancer site-specific comparisons were also made by race and sex.

(PDF emailed within 0-6 h: $19.90)

Accession: 012157571

Download citation: RISBibTeXText

DOI: 10.1007/s10552-004-1324-5



Related references

How representative are the surveillance, epidemiology, and end results (SEER) program cancer data of the United States?. Cancer Causes & Control 15(10): 1027-1034, 2005

Time trends in the epidemiology of newly diagnosed stage IV prostate cancer in the United States: An analysis of data from the Surveillance, Epidemiology, and End Results (SEER) Program (1988 - 2003). Journal of Clinical Oncology 26(15_suppl): 5059-5059, 2016

Building the infrastructure for nationwide cancer surveillance and control: A comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States). Cancer Causes and Control 14(2): 175-193, 2003

Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010. JAMA Oncology 1(1): 88-96, 2016

Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma. Journal of Registry Management 39(4): 158-166, 2014

The effect of marital status on survival in late-stage cancer patients: an analysis based on surveillance, epidemiology, and end results (SEER) data, in the United States. International Journal of Behavioral Medicine 6(2): 150-176, 2005

Survival analysis of distant prostate cancer by decade (1973-1997) in the Detroit Metropolitan Surveillance, Epidemiology and End Results (SEER) Program Registry: Has outcome improved? (United States). Cancer Causes and Control 14(7): 681-685, 2003

Recent time trends in the epidemiology of stage IV prostate cancer in the United States: analysis of data from the Surveillance, Epidemiology, and End Results Program. Urology 75(6): 1396-1404, 2010

Colorectal cancer incidence in the United States, 1999-2004 : an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program. Cancer 115(9): 1967-1976, 2009

Comparison of gastric cancer survival between Caucasian and Asian patients treated in the United States: results from the Surveillance Epidemiology and End Results (SEER) database. Annals of Surgical Oncology 22(9): 2965-2971, 2016

Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: An analysis of surveillance, epidemiology and end results program data. Journal of Urology 167(1): 57-60, January, 2002

Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. Journal of Urology 167(1): 57-60, 2001

Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program. International Journal of Epidemiology 29(2): 197-207, 2000

Estimating cancer mortality rates from surveillance epidemiology and end results seer program incidence and survival data. American Journal of Epidemiology 126(4): 760, 1987

Comparison of survival and clinicopathologic features in colorectal cancer among African American, Caucasian, and Chinese patients treated in the United States: Results from the surveillance epidemiology and end results (SEER) database. Oncotarget 6(32): 33935-33943, 2016